Loading stock data…
STE
$212.88+2.85 (+1.36%)
After Hours$212.88+0.00 (+0.00%)· Last close Jun 9
STERIS plc provides infection prevention products and services worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
STERIS plc in the Healthcare sector is trading at $212.88. Wall Street consensus targets $256.86 (7 analysts), implying a +20.7% move over the next 12 months. The stock is currently 21% below its 52-week high of $269.44, remaining 11.0% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$212.88
Potential Downside
0%
Whystock Fair Value$212.88
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus7 analysts
Buy
Mean target$256.86+20.7%
Range$225.00 – $280.00
Fundamentals
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assuran...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.59%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.86%
Volume
Today's trading volume
661,891
Recent News
Are Options Traders Betting on a Big Move in STERIS Stock?
Investors need to pay close attention to STE stock based on the movements in the options market lately.
3 Cash-Producing Stocks We Think Twice About
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Is STERIS (STE) Fairly Priced After Recent Share Price Weakness?
For investors considering whether STERIS, with a last close of US$212.35, is priced for opportunity or already reflects its strengths, this article walks through what the current share price may be implying about the stock's value. The stock is down 0.2% over the past week, 1.0% over the past month, 15.1% year to date and 12.0% over the past year, which may have some investors reassessing both risk and potential reward. Recent headlines have focused on STERIS as a key player in healthcare...
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 That Underwhelm
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
CBIZ Stock Is Down 60%. Here's What a $21.7 Million Exit Could Mean
CBIZ offers accounting, insurance, and advisory services to small and mid-sized clients in North America across three core segments.